Abstract
Owing to their self-organizing evolutionary plasticity, cancers remain evasive to modern treatment strategies. Previously, for sensitizing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant human fibrosarcoma (HT1080), we developed and validated a dynamic computational model that showed the inhibition of protein kinase (PK)C, using bisindolylmaleimide (BIS) I, enhances apoptosis with 95% cell death. Although promising, the long-term effect of remaining ~ 5% cells is a mystery. Will they remain unchanged or are they able to proliferate? To address this question, here we adopted a discrete spatiotemporal cellular automata model utilizing simple rules modified from the famous "Conway's game of life". Based on three experimental initializations: cell numbers obtained from untreated (high), treatment with TRAIL only (moderate), and treatment with TRAIL and BIS I (low), the simulations show cell proliferation in time and space. Notably, when all cells are fixed in their initial space, the proliferation is rapid for high and moderate cell numbers, however, slow and steady for low number of cells. However, when mesenchymal-like random movement was introduced, the proliferation becomes significant even for low cel...Continue Reading
References
Jan 7, 1993·Journal of Theoretical Biology·G B Ermentrout, L Edelstein-Keshet
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Dec 1, 1995·Immunity·S R WileyC A Smith
Oct 18, 2005·The Journal of Biological Chemistry·Eugene VarfolomeevAvi Ashkenazi
Nov 17, 2005·Oncogene·Lionel Larue, Alfonso Bellacosa
Jun 26, 2007·Cells, Tissues, Organs·Christine L ChafferElizabeth D Williams
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Jan 26, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Melissa G MendezRobert D Goldman
Jun 4, 2011·Cellular and Molecular Life Sciences : CMLS·Arun Satelli, Shulin Li
Jan 5, 2012·PLoS Computational Biology·Yang Jiao, Salvatore Torquato
Feb 23, 2012·Scientific Reports·Vincent PirasKumar Selvarajoo
Apr 24, 2013·Methods : a Companion to Methods in Enzymology·Markus Rehm, Jochen H M Prehn
Aug 7, 2013·Interface Focus·Philip K MainiS Seirin Lee
Nov 10, 2013·Cell Communication and Signaling : CCS·Kentaro HayashiKumar Selvarajoo
May 31, 2014·Cell Death & Disease·M L WürstleM Rehm
Sep 4, 2014·Journal of Biological Engineering·Kumar Selvarajoo
Jan 21, 2015·Frontiers in Immunology·Kentaro HayashiKumar Selvarajoo
Jul 15, 2015·Nature Reviews. Cancer·Amy BrockDonald E Ingber
Sep 12, 2015·Journal of Cancer Research and Clinical Oncology·Jie ZhangYu Jiang
Nov 13, 2015·Current Cancer Drug Targets·Yasumichi InoueHidetoshi Hayashi
Jun 4, 2016·PloS One·Mikiro TakaishiShigetoshi Sano
Jun 14, 2017·Nature·Sydney M ShafferArjun Raj
Nov 10, 2017·Methods in Molecular Biology·Kumar Selvarajoo
Nov 24, 2018·Nature Communications·Ankur SharmaRamanuj DasGupta
Citations
Nov 23, 2019·BMC Research Notes·William Deveaux, Kumar Selvarajoo
Apr 13, 2021·Physics of Life Reviews·Kumar Selvarajoo
Jun 13, 2021·Physics of Life Reviews·Mariano Bizzarri, Paola Pontecorvi